Creative Planning
SRNE

Creative Planning’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Creative Planning’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-51,362
Closed -$45.5K – 2819
2022
Q4 		$45.5K Sell
51,362
-1,321
-3% -$1.75K ﹤0.01% 2241
2022
Q3 		$83K Buy
52,683
+5,365
+11% +$12.2K ﹤0.01% 2060
2022
Q2 		$95K Buy
47,318
+8,880
+23% +$15.4K ﹤0.01% 1978
2022
Q1 		$90K Buy
+38,438
New +$120K ﹤0.01% 2005
2021
Q4 		– Sell
-15,443
Closed -$118K – 2246
2021
Q3 		$118K Sell
15,443
-7,261
-32% -$61.6K ﹤0.01% 1926
2021
Q2 		$220K Sell
22,704
-51,874
-70% -$413K ﹤0.01% 1754
2021
Q1 		$617K Sell
74,578
-5,802
-7% -$61.3K ﹤0.01% 1290
2020
Q4 		$549K Buy
80,380
+18,763
+30% +$151K ﹤0.01% 1257
2020
Q3 		$687K Buy
61,617
+14,392
+30% +$132K ﹤0.01% 963
2020
Q2 		$297K Buy
47,225
+37,095
+366% +$142K ﹤0.01% 1312
2020
Q1 		$19K Buy
+10,130
New +$29.2K ﹤0.01% 1728
2019
Q1 		– Sell
-16,000
Closed -$38K – 2114
2018
Q4 		$38K Hold
16,000
– – ﹤0.01% 1739
2018
Q3 		$70K Hold
16,000
– – ﹤0.01% 1837
2018
Q2 		$115K Sell
16,000
-4,350
-21% -$29.6K ﹤0.01% 1746
2018
Q1 		$105K Buy
20,350
+2,750
+16% +$19.6K ﹤0.01% 1743
2017
Q4 		$67K Sell
17,600
-8,002
-31% -$20.8K ﹤0.01% 1777
2017
Q3 		$44K Buy
25,602
+2
+0% +$4 ﹤0.01% 1788
2017
Q2 		$51K Hold
25,600
– – ﹤0.01% 2500
2017
Q1 		$101K Sell
25,600
-3,000
-10% -$15K ﹤0.01% 1962
2016
Q4 		$140K Sell
28,600
-425
-1% -$2.55K ﹤0.01% 1630
2016
Q3 		$225K Buy
29,025
+425
+1% +$2.86K ﹤0.01% 1337
2016
Q2 		$160K Hold
28,600
– – ﹤0.01% 1376
2016
Q1 		$154K Hold
28,600
– – ﹤0.01% 1358
2015
Q4 		$249K Buy
28,600
+24,000
+522% +$202K ﹤0.01% 1083
2015
Q3 		$39K Buy
+4,600
New +$73.3K ﹤0.01% 2230
2015
Q2 		– Sell
-1,900
Closed -$22K – 3263
2015
Q1 		$22K Hold
1,900
– – ﹤0.01% 2652
2014
Q4 		$19K Buy
1,900
+300
+19% +$1.52K ﹤0.01% 2707
2014
Q3 		$7K Buy
+1,600
New +$8.59K ﹤0.01% 3152

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Creative Planning's SRNE Position: Q1 2023 in Review

Creative Planning sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 51,362 shares — an estimated $45.5K sold.

Creative Planning first reported a position in SRNE in Q3 2014 and held it in 28 quarters. The position peaked at $687K in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Creative Planning reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Creative Planning sold 51,362 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $45.5K.
  • Creative Planning first reported a position in Sorrento Therapeutics, Inc. in Q3 2014 and held it in 28 quarters.
  • Creative Planning's Sorrento Therapeutics, Inc. position peaked at $687K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Creative Planning's 13F filing for Q1 2023, filed 15 May 2023.